Atrium Therapeutics (RNA) Margins & Profitability 2026
Gross, EBITDA, operating, and net margin trends
Margins
Profit margins across the income statement
- Gross Margin
- 100.0%
- EBITDA Margin
- -741.5%
- Op. Margin
- -752.9%
- Net Margin
- -672.0%
Gross Margin (%)
Revenue left after direct cost of goods sold
EBITDA Margin (%)
Operating profitability independent of capital structure
Operating & Net Margins (%)
How much of each dollar becomes profit